Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,055,569 papers from all fields of science
Search
Sign In
Create Free Account
rRNA synthesis
Known as:
rRNA biosynthesis
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Narrower (1)
rRNA transcription
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
rRNA synthesis inhibitor, CX-5461, activates ATM/ATR pathway in acute lymphoblastic leukemia, arrests cells in G2 phase and induces apoptosis
Sandeep S. Negi
,
P. Brown
OncoTarget
2015
Corpus ID: 12010544
Ribosome biogenesis is a fundamental cellular process and is elevated in cancer cells. As one of the most energy consuming…
Expand
2015
2015
Transient rRNA synthesis inhibition with CX-5461 is sufficient to elicit growth arrest and cell death in acute lymphoblastic leukemia cells
Sandeep S. Negi
,
P. Brown
OncoTarget
2015
Corpus ID: 9954883
Enhanced rRNA synthesis is a downstream effect of many of the signaling pathways that are aberrantly activated in cancer, such as…
Expand
2014
2014
Involvement of rRNA biosynthesis in the regulation of CUC1 gene expression and pre-meristematic cell mound formation during shoot regeneration
Naoki Shinohara
,
Iwai Ohbayashi
,
M. Sugiyama
Frontiers in Plant Science
2014
Corpus ID: 18759554
At an early stage of shoot regeneration from calli of Arabidopsis, pre-meristematic cell mounds develop in association with…
Expand
2013
2013
CRM1 and its ribosome export adaptor NMD3 localize to the nucleolus and affect rRNA synthesis
Baoyan Bai
,
Henna M. Moore
,
M. Laiho
The Nucleus
2013
Corpus ID: 31431657
CRM1 is an export factor that together with its adaptor NMD3 transports numerous cargo molecules from the nucleus to cytoplasm…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE